TJX
66
11
AES
55
-3
EL
56
4
MSFT
40
-3
CPB
39
2
BLK
61
-5
WHR
57
-2
RSG
51
3
MSI
35
-3
QRVO
48
-5
WY
54
-2
R
73
-7
MAT
45
-7
CCL
65
-3
EA
63
3
CVX
25
-4
AIZ
59
-2
PG
43
3
EW
50
-3
AMG
75
-7
TJX
66
11
AES
55
-3
EL
56
4
MSFT
40
-3
CPB
39
2
BLK
61
-5
WHR
57
-2
RSG
51
3
MSI
35
-3
QRVO
48
-5
WY
54
-2
R
73
-7
MAT
45
-7
CCL
65
-3
EA
63
3
CVX
25
-4
AIZ
59
-2
PG
43
3
EW
50
-3
AMG
75
-7
Financhill
Back

Vanguard S&P Small-Cap 600 Growth Index Fund ETF Vs. Nektar Therapeutics Sector Stock Comparison

Buy
65

VIOG
Vanguard S&P Small-Cap 600 Growth Index Fund ETF

Last Price:
$126.34
Seasonality Move:
1.47%
Sell
39

NKTR
Nektar Therapeutics

Last Price:
$53.66
Seasonality Move:
11.58%
Buy
65
Vanguard S&P Small-Cap 600 Growth Index Fund ETF (VIOG) is a Buy

Is Vanguard S&P Small-Cap 600 Growth Index Fund ETF a Buy, Sell or Hold?

  • The current Vanguard S&P Small-Cap 600 Growth Index Fund ETF [VIOG] share price is $125.53. The Score for VIOG is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • VIOG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VIOG Stock Price Chart

What is Vanguard S&P Small-Cap 600 Growth Index Fund ETF's stock price today?

  • The Vanguard S&P Small-Cap 600 Growth Index Fund ETF share price today is $125.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VIOG is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

VIOG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 19.47 Buy
Relative Strength Index (14 RSI): 62.64 Buy
Chaikin Money Flow: -7776 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (117.66 - 124.28) Buy
Bollinger Bands (100): (117.42 - 123) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

VIOG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 124.35 Buy
20-day SMA: 121.16 Buy
50-day SMA: 121.06 Buy
200-day SMA: 114.74 Buy
8-day EMA: 124.02 Buy
20-day EMA: 110.48 Buy
50-day EMA: 73.23 Buy
200-day EMA: 24.9 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

Vanguard S&P Small-Cap 600 Growth Index Fund ETF Earnings Growth & VIOG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Vanguard S&P Small-Cap 600 Growth Index Fund ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):